CCL2 and breast cancer: Thus, blocking CCL2-mediated crosstalk between breast cancer cells and normal endothelial cells could be an approach to improve efficacy of endocrine therapy, especially considering that disruption of CCL2-CCR2 axis was proved to inhibit breast cancer cell proliferation and invasion in our current study.